continu believ signific upsid share even follow
recent run manag care management deliv commit return
servic posit y/i growth allevi last concern
abil drive growth pbm believ ci posit drive adj ep
growth toward high-end tgt rang
ci expect grow within long-term target rang next year adj
ep baselin exclud headwind relat compani guidanc
assum prior period develop ep first nine month
impact one-tim favor tax benefit
hif headwind estim non-deduct portion headwind impli
adj ep start point approxim
believ like upsid compani initi guidanc first absenc
favor prior year develop function guidanc actual headwind
reserv develop in-lin manag expect benefit
earn howev reserv develop better expect even amount
favor develop y/i still repres sourc upsid rel
way ci guid favor pyd first nine month
compar assum normal level favor pyd
estim could add ep upsid cours year second ci
guidanc assum share repurchas assum share repurchas
y/i reflect pull forward share repurchas origin plan
increas use parent cash pay debt next year estim could add anoth
earn togeth estim two item could add roughli ep
compani guidanc rang
result guidanc impli continu ramp servic profit
ramp cost effici reach full run-rate fix cost
de-lever associ transit repres headwind
servic earn next year strand fix cost roll year progress
result slight earn shift rel previou model
estim adjust oper incom vs
prior project differ
rais full year adj ep estim
estim decreas even though lower
estim slightli believ two key posit takeaway quarter
first impli profit ramp second think solid
result impli guidanc allevi last concern
manag abil drive growth pbm boost investor confid
manag abil achiev target adj ep adjust
model bring adj ep estim still believ
compani posit drive growth toward high-end target rang
pleas see page report import disclosur
posit share ci believ acquisit esrx posit compani
succeed evolv healthcar landscap stand-alon basi ci carv
strong posit market particularli aso recent result demonstr
abil deliv strong result led critic compani spend
billion acquir esrx reflect rel depress valuat compar peer
believ unwarr believ investor may give enough credit
near-term growth opportun yet outlin beyond million cost synergi
greater purchas scale esrx ci posit full-risk
aso market believ strateg valu esrx even potenti
near-term accret lie long-term posit market shift toward greater care
coordin value-bas care
oper earn grow y/i
grow y/i
stronger expect medic custom
realiz pre-tax cost synergi excess
integr challeng lower
expect synergi esrx deal
global health servic compani subsidiari offer medic dental
disabl life accid insur relat product servic
product servic offer employ group select
intern market offer supplement health life accid insur product
intern health care coverag servic busi government non-
government organ individu decemb acquir
script largest pharmaci benefit manag script servic includ
drug util review formulari manag diseas manag medic drug
data analysi servic medic inform manag servic oper five
segment integr medic intern market oper
corpor
slightli lower price target impli price-to-earnings multipl
adj ep continu believ valuat attract stock current
trade adj ep estim even recent run share
price target suggest upsid rel current level
compani report cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end decemb cowen
compani report cowen compani
invest cost benefit expens servic pharmaci oper non-control interest incom pre-tax adjust oper net non-control interest incom incom adjust oper share outstand fulli net incom reconcili net chang servic incom end decemb cowen
compani report cowen compani
invest cost benefit expens servic pharmaci oper non-control interest incom pre-tax adjust oper net non-control interest incom loss adjust incom adjust oper share outstand fulli net incom reconcili amort acquir intang realiz gain chang y/i invest cost benefit servic pre-tax incom cowen
compani report cowen compani
receiv current polici acquisit tax asset asset account insur contracthold servic cost expens insur contracthold tax liabil non-curr account non-controlling equitycommon paid comprehens treasuri stock sharehold liabil sharehold liquid ratio current receiv claim payabl structur long-term solvenc ratio return invest capit averag total asset averag stockhold equiti end decemb cowen
compani report cowen compani
invest gain incom extinguish chang asset liabil net non-oper effect account polici acquisit servic cost payabl accru expens oper net cash equip purchas invest repay debt common common foreign currenc rate chang cash cash increas decreas end decemb cowen
compani report cowen compani
invest gain loss incom tax benefit extinguish chang asset liabil net non-oper effect account polici acquisit servic cost payabl accru expens oper invest sold fix matur equiti matur repay fix matur equiti sale matur purchas fix matur equiti primarili short-term equip net cash invest interest credit contracthold deposit benefit payment contracthold deposit chang short-term debt long-term proce issuanc long-term common common financ foreign currenc rate chang cash cash increas decreas cowen
valu manag care stock use pe multipl forward earn manag care
sector trade averag forward year earn past year
peak trough troubl econom time
frame given reform-rel multi-year top-lin growth prospect believ sector
trade high end recent histor valuat
success individu public exchang remain consider question mark
head third year program final year two three premium
stabil program reinsur risk corridor although exchang profit
expect improv expect continu money lose enterpris
industri particip receipt risk corridor payment remain potenti threat
success compani reli receiv medicar advantag payment
reduct includ potenti introduct new risk adjust model could
reduc futur medicar advantag margin growth prospect rel expect
gener medicaid payment expans popul gener
howev mount evid state like reduc payment level
medic cost trend mute past year uptick underli
medic cost may difficult predict product price within commerci
integr esrx anoth potenti risk particularli compani eventu move
ci live onto esrx platform also begin march began transit
membership pbm ingeniorx support disrupt could
impact ci note esrx tsa run
transit work move would need negoti
potenti propos hh regard futur rebat could impact ci
would expect potenti impact headlin risk vs meaning impact
remain chanc administr could propos sweep broad new
